Alterations of β-cell function and insulin properties underlay the metabolic syndrome that includes dyslipidemia, hyperglycemia, hypertension, impaired fibrinolysis, and atherosclerosis, thus contributing to lower insulin sensitivity [6]. This evidence concerns the gene INS and atherosclerosis.